Deutsche Bank Ag\ Allogene Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$248 Billion
Q4 2024

A detailed history of Deutsche Bank Ag\ transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 6,563 shares of ALLO stock, worth $17,063. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,563

Previous 69,179 90.51%

Holding current value

$17,063

Previous $193,000 93.26%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$1.84 - $3.22 $115,213 - $201,623	-62,616 Reduced 90.51%	6,563 $13,000
Q3 2024 Nov 13, 2024	BUY	$2.08 - $3.5 $64,467 - $108,479	30,994 Added 81.17%	69,179 $193,000
Q2 2024 Aug 14, 2024	SELL	$2.23 - $4.38 $14,938 - $29,341	-6,699 Reduced 14.93%	38,185 $88,000
Q1 2024 May 15, 2024	BUY	$2.92 - $5.63 $6,488 - $12,509	2,222 Added 5.21%	44,884 $200,000
Q4 2023 Feb 14, 2024	SELL	$2.28 - $3.5 $1,431 - $2,198	-628 Reduced 1.45%	42,662 $136,000
Q3 2023 Nov 09, 2023	SELL	$3.17 - $5.96 $614,269 - $1.15 Million	-193,776 Reduced 81.74%	43,290 $137,000
Q2 2023 Aug 14, 2023	SELL	$4.53 - $6.74 $955,304 - $1.42 Million	-210,884 Reduced 47.08%	237,066 $1.18 Million
Q1 2023 May 15, 2023	BUY	$4.92 - $8.21 $5,904 - $9,852	1,200 Added 0.27%	447,950 $2.21 Million
Q4 2022 Feb 13, 2023	BUY	$5.62 - $11.11 $38,997 - $77,092	6,939 Added 1.58%	446,750 $2.81 Million
Q3 2022 Nov 14, 2022	SELL	$10.32 - $17.28 $493,502 - $826,329	-47,820 Reduced 9.81%	439,811 $4.75 Million
Q2 2022 Aug 11, 2022	BUY	$6.78 - $12.28 $670,304 - $1.21 Million	98,865 Added 25.43%	487,631 $5.56 Million
Q1 2022 May 13, 2022	BUY	$7.65 - $15.29 $338,436 - $676,429	44,240 Added 12.84%	388,766 $3.54 Million
Q4 2021 Feb 11, 2022	BUY	$13.13 - $24.52 $1.75 Million - $3.26 Million	132,937 Added 62.83%	344,526 $5.14 Million
Q3 2021 Nov 04, 2021	SELL	$21.01 - $27.64 $466,295 - $613,442	-22,194 Reduced 9.49%	211,589 $5.44 Million
Q2 2021 Aug 11, 2021	BUY	$23.49 - $35.8 $794,713 - $1.21 Million	33,832 Added 16.92%	233,783 $6.1 Million
Q1 2021 May 13, 2021	SELL	$25.79 - $39.02 $1.57 Million - $2.38 Million	-60,967 Reduced 23.37%	199,951 $7.06 Million
Q4 2020 Feb 16, 2021	BUY	$25.24 - $43.45 $5.2 Million - $8.96 Million	206,099 Added 375.96%	260,918 $6.59 Million
Q3 2020 Nov 12, 2020	SELL	$32.38 - $44.96 $317,162 - $440,383	-9,795 Reduced 15.16%	54,819 $2.07 Million
Q2 2020 Aug 13, 2020	BUY	$18.39 - $54.04 $907,564 - $2.67 Million	49,351 Added 323.34%	64,614 $2.77 Million
Q1 2020 May 14, 2020	SELL	$18.22 - $28.25 $63,988 - $99,214	-3,512 Reduced 18.71%	15,263 $297,000
Q4 2019 Feb 14, 2020	BUY	$24.82 - $31.4 $180,962 - $228,937	7,291 Added 63.49%	18,775 $486,000
Q3 2019 Nov 14, 2019	SELL	$26.11 - $32.99 $268,410 - $339,137	-10,280 Reduced 47.23%	11,484 $312,000
Q2 2019 Aug 14, 2019	SELL	$25.56 - $31.09 $484,362 - $589,155	-18,950 Reduced 46.54%	21,764 $582,000
Q1 2019 May 15, 2019	BUY	$24.82 - $32.54 $84,735 - $111,091	3,414 Added 9.15%	40,714 $1.17 Million
Q4 2018 Feb 14, 2019	BUY	$22.5 - $33.3 $839,250 - $1.24 Million	37,300 New	37,300 $1 Million

Others Institutions Holding ALLO

# of Institutions

176

Shares Held

139M

Call Options Held

75.8K

Put Options Held

52.8K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $374M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account